Blog
RSS FeedPosted by Michael Wonder on 22 Aug 2020
NHS cannabis guidelines challenged in court
18 August 2020 - The parents of a three-year-old boy with severe epilepsy are going to court to mount the ...
Posted by Michael Wonder on 13 Jul 2020
Are high‐cost drug funding mechanisms fit for purpose? A retrospective study of individual funding requests in an NHS tertiary hospital
13 July 2020 - This paper reports on a retrospective study of individual funding request submissions from a large tertiary hospital ...
Posted by Michael Wonder on 05 Jul 2020
Britain nears $625 million Sanofi/GSK COVID-19 vaccine deal
5 July 2020 - Britain is close to a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for ...
Posted by Michael Wonder on 02 Jul 2020
Vertex announces expansion of reimbursement agreement with NHS England to include Kaftrio (ivacaftor/tezacaftor/elexacaftor) in combination with Kalydeco (ivacaftor)
30 June 2020 - Cystic fibrosis patients in England will be among the first in Europe to benefit from access to ...
Posted by Michael Wonder on 29 Jun 2020
Successful Eloctaq bid should widen access to the drug in the UK
29 June 2020 - The NHS and Sobi UK have come to an agreement that will give people living with ...
Posted by Michael Wonder on 23 Jun 2020
MHRA extends access to Santhera's DMD drug via the EAMS
23 June 2020 - The UK’s Medicines and Healthcare products Regulatory Agency has renewed for a further year the Early ...
Posted by Michael Wonder on 16 Mar 2020
HIV drug PrEP to be available across England
15 March 2020 - PrEP will be routinely available across England as part of the government’s aim to end HIV transmission ...
Posted by Michael Wonder on 06 Mar 2020
Girl loses High Court battle over NICE review of BioMarin’s phenylketonuria drug
5 March 2020 - An 11-year-old girl with the rare disease phenylketonuria has lost a legal battle in the High ...
Posted by Michael Wonder on 22 Feb 2020
UK deal over inclisiran
18 February 2020 - Government’s public enthusiasm looks premature given the lack of available data ...
Posted by Michael Wonder on 22 Feb 2020
Health ministers condemn Novartis lottery for Zolgensma, the world’s most expensive drug
12 February 2020 - Novartis has held the first draw to choose four babies who will receive its one-shot treatment ...
Posted by Michael Wonder on 30 Jan 2020
Brexit D-Day
31 January 2020 - After more than three years of Brexit talks, deals and political wrangling, the United Kingdom will officially ...
Posted by Michael Wonder on 29 Jan 2020
Cancer patients facing delays in getting ‘innovative’ drugs
29 January 2020 - A new analysis report has found that most innovative cancer drugs face delays in reaching patients. ...
Posted by Michael Wonder on 23 Jan 2020
Woman denied cancer drug on NHS which could extend her life because of where she lives
22 January 2020 - Ann, 64, can't get the drug she needs to survive because it's not available on the NHS ...
Posted by Michael Wonder on 16 Jan 2020
Breast cancer patients to have further NICE approved drug combination option on Cancer Drugs Fund
15 January 2020 - Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on ...
Posted by Michael Wonder on 13 Jan 2020
Novartis strikes deal with UK to provide cholesterol drug to high-risk patients
13 January 2020 - Pharmaceutical giant Novartis reached a deal with the U.K. to provide its late-stage cholesterol drug, inclisiran, to ...